← Back to articles

health

Health & Medicine

The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.

HIGH confidence neutral tone

Coverage (16356 articles)

geneonline.com · Aug 18, 2026

1 in 20 Australian Women Now Receiving IV Iron Infusions

One in 20 Australian women now receive intravenous iron infusions, marking a significant decade-long increase in this treatment approach, according to Flinders University research analyzing pharmaceutical benefits data.

Canberra Daily · Aug 18, 2026

ANU nanopore sensors could detect Alzheimer's 15 years early

ANU researchers have developed portable nanopore sensors that can detect Alzheimer's disease up to 15 years before symptoms appear by identifying individual protein molecules in blood, potentially revolutionizing early diagnosis.

miragenews.com · Aug 18, 2026

MIT Researcher Develops CRISPR Gene Therapy for Rare Childhood Epilepsy

Shannon Knight, a MIT doctoral researcher, is developing a CRISPR-based gene therapy to treat SYNGAP1 haploinsufficiency, a rare genetic disorder causing childhood-onset epilepsy and developmental challenges. Early mouse studies show promising results in alleviating seizures.

EurekAlert! · Aug 18, 2026

Iron IV use among Australian women surges 17-fold in a decade

Intravenous iron treatment use among Australian women aged 18-44 has increased 17-fold since 2013, with one in 20 women now receiving the therapy annually. Government spending on the medication rose from $1.1M to $82M, though access and completion rates vary significantly by region and socioeconomic status.

← Previous Page 95 of 682 Next →
Contact Us FAQ